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Abstract 
Primary  hepatic  angiosarcoma  is  a  rare
and  rapidly  fatal  disease.  We  present  the
highly  unusual  identification  of  this  lesion
five years after the initial clinical presenta-
tion. 
In 2003, a 32-year-old man presented with
abdominal pain, tachycardia, and evidence of
hemorrhage.  A  CT  scan  showed  a  hepatic
mass  with  intralesional  hemorrhage,  intra-
peritoneal  blood,  and  splenomegaly.  The
patient was stabilized clinically. Laparoscopic
core  biopsies  demonstrated  no  malignancy,
only findings consistent with an old hemor-
rhage.  Contralateral  lobe  biopsies  revealed
normal liver tissue. A metastatic workup was
negative  and  the  decision  was  made  to
observe the patient clinically with radiograph-
ic follow-up, given his suspected portal hyper-
tension  based  on  thrombocytopenia  and
splenomegaly.
Sequential  imaging  demonstrated  a
decrease in the size of the mass from 12.0 cm
in 2003 to 3.0 cm in 2007. Subsequent newly
identified esophageal varices prompted a re-
evaluation  of  the  case.  A  repeat  biopsy
demonstrated a neoplasm of vascular etiology
and uncertain malignant potential. By early
2008 the lesion had increased to 4.8 cm and
was resected via a left hepatic lobectomy. An
extremely  vascular  lesion  with  surrounding
dense fibrosis was identified and pathologic
examination  demonstrated  a  high-grade
angiosarcoma.
We  are  unaware  of  any  previous  reports
suggesting such a prolonged natural history
of hepatic angiosarcoma. This case may rep-
resent the possibility of malignant transfor-
mation of a lower grade vascular neoplasm
such  as  hepatic  epithelioid  hemangioen-
dothelioma to an angiosarcoma. 
Introduction
Primary hepatic angiosarcoma is a rare dis-
ease with a poor life expectancy. It is believed
to be highly lethal, with near 100% mortality by
one year. We present the highly unusual iden-
tification of a high-grade angiosarcoma in an
adult male five years following his initial pres-
entation with a spontaneously bleeding hepat-
ic mass.
Case Report
The patient is a 32-year-old man with a his-
tory of Crohn’s disease, who presented febrile
and  tachycardic,  with  a  falling  hematocrit
(40.0-27.7%),  and  leukocytosis  (23  K/cm)  in
2003. An abdominal CT scan demonstrated a
12.0x11.0  cm  hyperdense,  highly  attenuated,
heterogeneous mass in the lateral segment of
the  left  hepatic  lobe,  with  a  free  intraperi-
toneal hemorrhage (Figure 1A). The patient
became stable hemodynamically after a trans-
fusion with two units of blood. In addition to
Crohn's disease, his past medical history was
notable for splenomegaly since the age of 18
years  and  persistent  thrombocytopenia
(platelet  count,  40,000-50,000).  He  denied
drinking  alcohol  and  subsequent  hepatitis
serology tests were negative. 
A fine needle aspiration of the left hepatic
mass  was  performed  and  demonstrated  rare
clusters of atypical cells with a background of
necrotic debris, suggestive of malignancy. The
paucity  of  cells  present,  however,  precluded
immunohistochemical workup and a definitive
diagnosis. Laparoscopic needle core biopsies
were performed subsequently and revealed an
organizing  hematoma  without  evidence  of
malignancy. Biopsies of the contralateral lobe
demonstrated normal liver parenchyma with-
out  cirrhosis.  A  full  metastatic  workup  was
negative. Hepatic angiography was performed
and  demonstrated  a  rounded  hypovascular
lesion  without  a  characteristic  tumor  blush.
Hepatic venous wedge pressures (8 torr) failed
to support a diagnosis of portal hypertension. A
bone  marrow  biopsy  was  unremarkable  and
platelet function assays were normal. A deci-
sion for close observation was made secondary
to  the  patient’s  long-standing  splenomegaly
and thrombocytopenia and the concern for his
suitability for resection.
The  patient  was  monitored  closely  every
four to six months with radiographic imaging,
which documented an interval decrease in the
size of the lesion (Figure 1B). He remained
asymptomatic,  fully  active,  and  otherwise
healthy. A surveillance CT scan performed four
years after the initial presentation (April 2007)
demonstrated the lesion had diminished to 3.0
cm  in  maximum  dimension,  but  with  newly
identified  asymptomatic  esophageal  varices
and thrombosis of the left portal vein. Over the
following eight months, the lesion increased in
size  from  3.0  cm  to  4.8  cm,  and  developed
prominent intralobular septations (Figure 1C). 
A  malignant  process  was  considered  and
repeat core biopsies demonstrated an atypical
vascular proliferation with features suggestive
of  an  epithelioid  hemangioendothelioma.
Subsequently  the  patient  underwent  a  left
hepatic  lobectomy  (Couinaud  segments  2-4)
that revealed a highly vascular lesion involving
the left lateral and left medial lobes with fibro-
sis of the porta hepatis. Pathologic examina-
tion demonstrated a high-grade primary hepat-
ic  angiosarcoma  with  negative  histological
margins.  The  patient’s  postoperative  course
was complicated by the development of signif-
icant ascites. He recovered well from surgery,
and the ascites resolved. A three-month follow-
up CT scan demonstrated a single pulmonary
lesion  suggestive  of  metastasis.  The  patient
underwent a video-assisted thoracoscopy pro-
cedure,  with  the  pathologic  examination
demonstrating a 1 cm focus of a high-grade
metastatic epithelioid angiosarcoma. He rapid-
ly developed a port site chest wall recurrence,
for  which  he  has  received  systemic  taxane-
based  chemotherapy,  with  a  durable  partial
response  of  twelve  months.  Currently  he
remains free of disease in the liver.
Pathologic findings
Grossly,  the  resected  liver  specimen  con-
tained  a  tan,  hemorrhagic  well-demarcated
mass (6.0x5.5x5.0 cm), with a peripheral rim
of fibrous tissue and approximately 60% tumor
necrosis (Figure 2). The mass abutted on the
capsular  surface  with  adjacent  fibropurulent
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serositis. Surgical resection margins were nor-
mal tissue.
Microscopically,  the  liver  mass  revealed  a
high-grade malignant neoplasm composed of
epithelioid  cells  exhibiting  marked  cellular
pleomorphism,  brisk  mitotic  activity  (>50
mitotic  figures/10  high  power  fields)  and
extensive geographic tumor necrosis (Figure
3). The cells were arranged in cohesive sheets,
focally forming anastomosing vascular chan-
nels with prominent hob-nailing and scattered
intracytoplasmic lumina. The tumor infiltrated
the  surrounding  hepatic  parenchyma  with
entrapment of benign bile ducts and hepato-
cytes. Lymphovascular invasion was not identi-
fied.  Positive  immunohistochemical  stains
included:  CD31,  CD34,  Podoplanin  (D2-40),
EMA, and Factor VIII Ag, while Keratin CAM
5.2,  Keratin  MAK  6,  Keratin  AE1-AE3,  and
HepPar1  were  negative.  The  immunohisto-
chemical findings support vascular differentia-
tion  with  high-grade  morphology,  extensive
necrosis, and epithelioid morphology charac-
teristic of an epithelioid angiosarcoma. 
Discussion
Angiosarcomas are rare, malignant vascular
tumors that may occur in any area of the body,
but are most common in the region of the head
and neck. Sarcomas of the soft tissues consti-
tute less than 1% of all cancers, with angiosar-
comas compromising approximately 2% of soft
tissue sarcomas. Predisposing factors include
a  prior  history  of  radiation  therapy,  chronic
lymphedema, exposure to Thorotrast (thorium
dioxide, a radiologic contrast medium), use of
anabolic steroids or synthetic estrogens, insec-
ticide  exposure,  and  long-term  exposure  to
vinyl  chloride.  Typically  angiosarcomas  are
high-grade,  aggressive  tumors  that  tend  to
recur  and  metastasize  despite  treatment.
Current therapies include surgical resection,
with  radiation  therapy  and/or  adjuvant
chemotherapy  depending  on  the  anatomic
location and size. Overall prognosis is poor for
soft  tissue  angiosarcomas,  with  a  five-year
survival reported in the range of 10-35%.
1
Hepatic angiosarcoma is very rare, consti-
tuting 2% of all primary hepatic cancers. The
average incidence of hepatic angiosarcoma is
estimated to be 25 cases per year in the United
States.  There  is  a  male  to  female  predomi-
nance of 3:1 with the majority of patients diag-
nosed  in  their  sixth  decade  of  life.
Approximately 60% of patients have evidence
of metastatic disease at the time of diagnosis.
2
Clinical presentation is nonspecific typical-
ly,  with  presenting  symptoms  including
abdominal pain, weakness, fatigue, and weight
loss; while physical examination findings may
include  hepatomegaly,  ascites,  and  jaundice.
Acute abdominal bleeds occur spontaneously
or following percutaneous biopsy in 15-27% of
cases, and thus hepatic angiosarcoma should
be considered in the differential workup of a
patient  with  spontaneous  hemoperitoneum.
Associated laboratory findings tend to be non-
specific,  although  more  than  half  of  the
patients  have  unexplained  thrombocytopenia
and elevated alkaline phosphatase levels. The
remaining liver function tests are normal and
tumor markers are negative. To date, there has
not  been  any  association  with  known  viral
markers identified.
3
Radiographically,  hepatic  angiosarcomas
have a varying appearance. There may be one
dominant focus or multiple masses that corre-
late with the gross appearance. Metastases are
common at the time of presentation, with the
most usual metastatic sites being the lung and
spleen. Unenhanced CT images of these mass-
es are observed to be hypodense when com-
pared  to  normal  hepatic  parenchyma,  while
lesions  observed  with  contrast-enhanced  CT
may be either hypo- or hyperdense, depending
on  the  presence  of  hemorrhage  within  the
tumor.  Optimal  imaging  techniques  for  the
diagnosis  of  hepatic  angiosarcoma  include
unenhanced,  multiple-phase  enhanced,  and
delayed CT or MR imaging to adequately cap-
ture  all  phases  of  the  tumor  and  eliminate
potentially benign mimickers.
4
Pathologically, hepatic angiosarcomas of the
deep soft tissue and in visceral locations gen-
erally  are  high-grade  malignant  neoplasms
Article
Figure  1.  CT  images
showing  regression
rather than progression
of the liver lesion, (A)
initial  presentation  in
2003,  (B)  diminished
to 3.0 cm in 2007, and
(C)  progression  in
2008.
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that  have  an  epithelioid  to  spindled  appear-
ance. As in the current case, angiosarcomas of
the liver are characterized by nests and solid
sheets of malignant cells of high nuclear grade
that  form  irregular  vascular  channels  and
exhibit invasion of the adjacent liver parenchy-
ma.    Tumor  necrosis  is  a  common  finding.
Grossly, the tumor may appear with one of four
different growth patterns: multiple nodules, a
single  dominant  mass,  mixed  patterns  of  a
dominant  mass  with  smaller  nodules,  or  an
infiltrating micronodular tumor.
2
For the past 40 years, a link has been estab-
lished  between  hepatic  angiosarcoma  and
environmental  toxins,  including  Thorotrast,
vinyl chloride, arsenic, radiation, and exoge-
nous estrogens or anabolic steroids. However,
in nearly 75% of cases, no causative agent is
identified. In all cases of environmental expo-
sure,  a  prolonged  latency  period  has  been
established of 20-30 years on average, yet the
gross and microscopic pathology of idiopathic
angiosarcomas and those caused by environ-
mental toxins remain identical.
5
Treatment  for  hepatic  angiosarcoma  is
delayed often owing to the nonspecific symp-
toms with which the tumor typically presents.
The average time until diagnosis is six months
from the initial presentation to a health care
professional;  however,  many  patients  do  not
seek medical attention for several months fol-
lowing the onset of symptoms. Thus, a large
tumor size and the presence of metastases are
common on diagnosis. Median survival time
following diagnosis is six months, with near
100% mortality by one year. Improved progno-
sis  has  been  observed  with  a  single  tumor
mass, a smaller tumor size, lack of metastases,
a  low-grade  lesion,  and  negative  surgical
resection  margins;  however,  owing  to  the
infrequent nature of the tumor, this still has to
be  quantified.
2 Given  the  poor  prognosis  for
patients  diagnosed  with  hepatic  angiosarco-
ma,  surgical  resection  is  the  only  definitive
treatment;  however,  this  is  not  possible  in
many cases either because of multifocal dis-
ease or the extent of the liver involvement.
6
Adjuvant treatment remains undefined owing
to the rarity of the tumor. Chemotherapy has
not been well studied except on a case report
basis,  and  in  general  angiosarcomas  are
resistant to radiation therapy. Liver transplan-
tation  has  been  attempted,  but  the  tumor
recurrence rate remains high (64%) and long-
term survival has not been observed (average
survival time, 23 mth).
7 If definitive resection
can be achieved prior to microscopic spread of
the  disease,  long-term  survival  is  possible.
This has been reported in three adult cases
that were without evidence of recurrence at 64
months, 38 months, and 10 years.
3
Although our patient’s tumor was amenable
to  resection,  the  associated  hepatic  fibrosis
documented by previous core biopsies and the
clinical diagnosis of portal hypertension por-
tends a worse prognosis. Pathologic examina-
tion results including high-grade nuclear fea-
tures  with  epithelioid  morphology  are  addi-
tional unfavorable findings. Paradoxically, the
radiographic finding of a tumor mass that had
been present for the previous five years in our
patient would suggest a less aggressive clinical
course of the disease.  
In  hindsight,  this  patient’s  splenomegaly
appears to be a result of periportal fibrosis and
the splenomegaly and thrombocytopenia were
long  standing.  These  clinical  findings  have
been reported previously as precursors to the
development  of  angiosarcoma  in  other
patients. An analysis of patients with signifi-
cant polyvinyl chloride exposure by Lee et al.
(1996)
8 described a patient with a history of
splenomegaly and thrombocytopenia, who later
presented with esophageal varices and presi-
nusoidal  hypertension  via  a  screening  pro-
gram. Ultimately a core needle biopsy lead to
the diagnosis of presinusoidal hepatic fibrosis.
The  patient  later  sustained  a  fatal  gastroin-
testinal hemorrhage, and at autopsy was found
to have primary hepatic angiosarcoma.
8 In the
case of our patient, liver biopsies of the unin-
volved liver in 2003 failed to demonstrate char-
acteristic periportal fibrosis, but this was iden-
tified on repeat liver biopsies in 2007, after the
patient developed esophageal varices.
We are unaware of any previous reports sug-
gesting such a prolonged natural history of a
hepatic angiosarcoma. This case may repre-
sent the possibility of malignant transforma-
tion of a lower grade vascular neoplasm, such
as hepatic epithelioid hemangioendothelioma,
to  a  more  aggressive  angiosarcoma.  While
angiosarcoma may present with spontaneous
and often catastrophic intraperitoneal bleed-
ing, this patient’s spontaneous intraperitoneal
bleed was five years prior to eventual resection
of the tumor. The patient had well-documented
radiographic gradual reduction in size of the
lesion over four and a half years, before its
rapid enlargement just prior to excision; a very
unusual progression in the natural history of a
high-grade  angiosarcoma,  thus  raising  the
possibility  of  malignant  transformation  of  a
benign precursor. 
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Figure 3. Hepatic mass
and  adjacent  liver
parenchyma with asso-
ciated capsular disrup-
tion and inflammatory
reaction  (H&E  stain,
40x magnification).
Figure  2.  Gross  liver
resection specimen.[Rare Tumors 2009; 1:e33] [page 101]
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